Evaluation of [<sup>89</sup>Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer-Reference-Cited by-同舟云学术

Evaluation of [⁸⁹Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer

Published:2023-08-08 Issue:9 Volume:20 Page:4629-4639
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ducharme Maxwell¹^ORCID,Hall Lucinda¹^ORCID,Eckenroad Whitney¹,Cingoranelli Shelbie J.¹²,Houson Hailey A.¹,Jaskowski Luke¹²,Hunter Chanelle¹,Larimer Benjamin M.¹^ORCID,Lapi Suzanne E.¹²

Affiliation:

1. Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama 35233, United States

2. Department of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35233, United States

Funder

University of Alabama at Birmingham

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00360

Reference53 articles.

1. Breast Cancer Treatment

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Biology of HER2 and Its Importance in Breast Cancer

4. HER2: Biology, Detection, and Clinical Implications

5. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

2. Development of 52Mn Labeled Trastuzumab for Extended Time Point PET Imaging of HER2;Molecular Imaging and Biology;2024-08-27

3. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [⁸⁹Zr]Zr-TR1402;Molecular Pharmaceutics;2024-07-08

4. Good practices for 89Zr radiopharmaceutical production and quality control;EJNMMI Radiopharmacy and Chemistry;2024-05-11

5. Advances in Radioligand Theranostics in Oncology;Molecular Diagnosis & Therapy;2024-03-31